Skip to main navigation Skip to search Skip to main content

Cerebrotendinous xanthomatosis presenting with severe externalized disorder: Improvement after one year of treatment with chenodeoxycholic acid

  • Olivier Bonnot
  • , Matthew J. Fraidakis
  • , Raffaella Lucanto
  • , Dominique Chauvin
  • , Nathalie Kelley
  • , Monique Plaza
  • , Odile Dubourg
  • , Olivier Lyon-Caen
  • , Frédéric Sedel
  • , David Cohen

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

Cerebrotendinous xanthomatosis (CTX) is a rare inborn disorder of sterol storage with autosomal recessive inheritance and a variable clinical presentation. We describe two siblings with an early psychiatric presentation of CTX-associated attention-deficit/hyperactivity disorder and oppositional defiant disorder, also associated with a mild intellectual disability and major behavioral impairments. In both cases, treatment with chenodeoxycholic acid improved externalized symptoms and a partial recovery of cognitive impairments was observed. This suggests that CTX is potentially reversible, demonstrating the need for early diagnosis and treatment of this disorder before irreversible neurological lesions can occur.

Original languageEnglish
Pages (from-to)231-236
Number of pages6
JournalCNS Spectrums
Volume15
Issue number4
DOIs
StatePublished - Apr 2010
Externally publishedYes

Fingerprint

Dive into the research topics of 'Cerebrotendinous xanthomatosis presenting with severe externalized disorder: Improvement after one year of treatment with chenodeoxycholic acid'. Together they form a unique fingerprint.

Cite this